Intraductal Papillary Mucinous Neoplasm With Malignant Change

Intraductal Papillary Mucinous Neoplasm (IPMN) With Malignant Change: Prospective Study to Assess Diagnostic Performance of CT and Magnetic Resonance Imaging (MR) According to International Consensus Guidelines 2012

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02044926

Enrollment

Registered

2014-01-24

Start date

2014-01-31

Completion date

2016-07-31

Last updated

2016-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IPMN

Brief summary

Purpose: To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012. Hypothesis: According to 2012 consensus guidelines, enhanced solid component and main pancreatic duct size of larger than 10 mm will be significant.

Detailed description

1. Purpose * To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012 2. Enroll criteria * Patient who is suspected to have pancreas IPMN on imaging * Interval between imaging study and surgery is less than 2 months * Who is scheduled for surgery due to IPMN

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients who is suspected to have IPMN by imaging study or clinician * Time interval between imaging study and surgery less than 2 months

Exclusion criteria

* Patients who have pathology results not by surgery * Who is less than 20 years old * Who cannot voluntarily agree study design

Design outcomes

Primary

Measure	Time frame	Description
Imaging predictor of malignant IPMN of the pancreas	one month	We will assess baseline CT and MRI findings of patients within one month after surgery.

Countries

South Korea

Outcome results